rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Globally we show a sex-specific benefit of dietary DHA supplementation in the G93A ALS mouse model, compared with mice fed an isocaloric control or a n-3-depleted diet.
|
31755041 |
2020 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Accumulation of DNA damage has been detected in the spinal cord of patients as well as in the G93A mouse model of amyotrophic lateral sclerosis (ALS).
|
31676238 |
2020 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Compensatory changes in degenerating spinal motoneurons sustain functional sparing in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
|
31364764 |
2020 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1<sup>G93A</sup> ) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes.
|
31412164 |
2020 |
rs80265967
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
|
31830646 |
2020 |
rs121912436
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Our results showed that urate treatment provided neuroprotective effects as confirmed by enhanced survival, attenuated motor impairments, reduced oxidative damage and increased antioxidant defense in hSOD1-G85R-expressing Drosophila models of ALS.
|
30690059 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Histidine treatment in SOD1-G93A mice proved broad efficacy in ameliorating ALS features, among which most importantly lifespan, motor performance, microgliosis, muscle atrophy, and motor neurons survival in vivo and in vitro.
|
31020811 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We identified a total of 10 studies; nine studies using cannabinoid treatment in transgenic SOD1-G93A ALS-model mice and one study in TDP-43 transgenic mice.
|
30520038 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
As a result, genistein alleviated ALS-related symptoms and slightly prolonged the lifespan of SOD1-G93A mice.
|
31321663 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In this study, we detected higher expression levels of Hypoxia-inducible factor 1-alpha (HIF-1α), a key regulator of cellular responses to hypoxia, in the spinal cord of ALS patients and in the transgenic mice overexpressing the familial ALS-associated G93A SOD1 mutation (mSOD1<sup>G93A</sup> mice) compared to controls.
|
30918303 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
An Allosteric Pathway in Copper, Zinc Superoxide Dismutase Unravels the Molecular Mechanism of the G93A Amyotrophic Lateral Sclerosis-Linked Mutation.
|
31747286 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In the present study, we investigated hypoxic stress in ALS model mice bearing G93A-human Cu/Zn superoxide dismutase by in vivo HIF-1α imaging, and treated the ALS mice with DMOG.
|
31344397 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Here, we used a similar longitudinal approach in the Cu/Zn superoxide dismutase (SOD1[G93A]) mouse model of ALS.
|
30370671 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
These results suggest that a deeper characterization of mechanisms involved in PACAP/EGFR/MMP-2 axis activation in G93A SOD1 mutated neurons may allow identifying new targets for ALS therapy.
|
30238989 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Mutations in several proteins have been linked to ALS pathogenesis, including the G93A mutation in the superoxide dismutase 1 (SOD1) enzyme.
|
30439413 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In this study, we employed orthogonal cellular synchrotron radiation based spectro-microscopies to investigate the astrocytes of an ALS animal model: the rat hSOD1 G93A that overexpresses human mutated SOD1, which is known to increase the susceptibility of the SOD1 protein to form insoluble intracellular aggregates.
|
30571081 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Using a rodent model of ALS overexpressing mutant human Cu/Zn-superoxide dismutase gene (SOD1-G93A), we performed a comparative lipidomic analysis in motor cortex and spinal cord tissues of SOD1-G93A and WT rats at asymptomatic (~70 days) and symptomatic stages (~120 days).
|
31406145 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
(4) Conclusion: Besides the established histaminergic neuroprotective and anti-inflammatory effects, the induction of the heat shock response in the SOD1-G93A model by histamine confirms the importance of this pathway in the search for successful therapeutic solutions to treat ALS.
|
31382568 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In two different transgenic (Tg) mouse models of adult-onset neurodegenerative disease, a human A53T-α-synuclein (hαSyn) model of Parkinson's disease (PD) and a human G93A-superoxide dismutase-1(hSOD1) model of amyotrophic lateral sclerosis (ALS), mortality and survivor morbidity were significantly greater than non-Tg mice and a Tg mouse model of Alzheimer's disease after neonatal traumatic brain injury (TBI).
|
31275228 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Furthermore, we found that S100A4 was significantly up-regulated in astrocytes and microglia in the spinal cord of a transgenic rat SOD1-G93A model of amyotrophic lateral sclerosis.
|
31623154 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In agreement, the hSOD1 G93A mouse model reveals that ALS-resistant CrMNs accumulate less insoluble hSOD1 and p62-containing inclusions than SpMNs.
|
31157617 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In humans, mutation of glycine 93 to alanine of Cu<sup>++</sup>/Zn<sup>++</sup> superoxide dismutase type-1 (SOD1-G93 A) has been associated to some familial cases of Amyotrophic Lateral Sclerosis (ALS).
|
30503815 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
These observations prompted us to a thorough investigation of SOCE in primary astrocytes from the spinal cord of the SOD1(G93A) ALS mouse model in comparison with the SOD1(WT)-expressing controls.
|
31627428 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The same experiments were repeated using SH-SY5Y cells carrying the familial ALS-related G93A-SOD1 mutation and constitutively expressing two-fold increased whole-cell ROS levels with respect to wild-type cells: riluzole was ineffective in this paradigm.
|
31352711 |
2019 |
rs121912438
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Recent studies have reported pathological abnormalities in oligodendrocytes in human patients with amyotrophic lateral sclerosis (ALS) and a mouse model of ALS expressing the G93A mutation of the human superoxide dismutase 1 (mtSOD1).
|
31290185 |
2019 |